Domenica Lorusso, MD, PhD, presents the final overall survival data from the randomized open -label phase 2 trial of relacorilant, a selective glucocorticoid receptor modulator in combination with nab-paclitaxel versus nab-paclitaxel alone in patients with recurrent platinum resistant ovarian cancer.
Read More
The Future of Endometrial Cancer Treatment
Experts give insight on what they are looking forward to in the endometrial cancer space.
Read More
A Look at Surgical Innovations in EC
Nicoletta Colombo, MD, PhD, reviews surgical advancements in endometrial cancer.
Read More
Novel Targets of Interest in EC
Experts in endometrial cancer comment on novel targets of interest that are currently being investigated.
Read More
Insight on Ongoing Trials in EC
Key opinion leaders take a look at the evolving treatment landscape in endometrial cancer, discussing ongoing trials in the space.
Read More
Incorporating Molecular Features into Choosing Adjuvant Therapy
Experts discuss the importance of incorporating molecular features into the selection of adjuvant treatment.
Read More
Therapeutic Sequencing in Endometrial Cancer
Experts in endometrial cancer comment on therapeutic sequencing in endometrial cancer.
Read More
Managing AEs With Pembrolizumab and Lenvatinib
Key opinion leaders emphasize the importance of the management of adverse events in using pembrolizumab and lenvatinib.
Read More
Experience in Using Pembrolizumab + Lenvatinib in Advanced Endometrial Cancer
Experts give insight on their clinical use of pembrolizumab-lenvatinib. They highlight dose adjustments and the importance of the increased knowledge of adverse events.
Read More
A Discussion on the Study 309/KEYNOTE-775 Data
Key opinion leaders discuss the presented data from Study 309/KEYNOTE-775, highlighting patient reported outcomes, safety, and dosing.
Read More
Results from Study 309/KEYNOTE-775
Vicky Makker, MD, presents the results from Study 309/KEYNOTE-775, as well as key safety findings.
Read More
Study 309/KEYNOTE-775 Trial Design
Vicky Makker, MD, walks through the trial design of Study 309/KEYNOTE-775.
Read More
Therapeutic Approaches in Endometrial Cancer
Experts review optimal approaches to treatment in advanced endometrial cancer, touching on clinical trial data.
Read More
Biomarker Testing and Multidisciplinary Approaches in EC
Key opinion leaders share their thoughts on biomarker testing and multidisciplinary approaches for endometrial cancer at their institutions globally.
Read More
Heterogeneity of Endometrial Cancer
Experts in gynecologic cancer discuss the heterogeneity of endometrial cancer..
Read More